Riskpilot← Back to searchSign inGet full accessMedicator Aktiebolag
ABActiveOrg 5562275445Violstigen 4 NbBusiness and other management consultancy activities · NACE 7020Est. 19831 employees
Revenue 2025
SEK 762K
-49% vs 2024
EBITDA margin
-46.0%
-234% vs 2024
Equity ratio
84.6%
Financial strength
Net profit 2025
SEK 2K
-99% vs 2024
| Revenue | SEK 762K | -49% |
| EBITDA | SEK -351K | -234% |
| Net profit | SEK 2K | -99% |
| Total assets | SEK 4,9M | -10% |
| Equity | SEK 4,2M | +0% |
| Employees | 1 | — |
Legal name
Medicator Aktiebolag
Org number
5562275445
Legal form
Aktiebolag
NACE code
7020 · Business and other management consultancy activities
Founded
6 april 1983
Share capital
SEK 100 000
Employees
1 (FTE)
VAT registered
Yes
Audit selected
No
Last report
2025-12-31
Financial year
January – December
Signatory rights
Firman tecknas av styrelsen Firman tecknas var för sig av ledamöterna
Company purpose
Aktiebolaget ska bedriva föreläsningar och konsultverksamhet inom ledarskap, branding och marknadsföring ävensom äga och förvalta fast och lös egendom.
Address
Violstigen 4 Nb
Phone
+4629220068
Email
jeppa.ek@gmail.com
Risika for professionals
Risika provides regulated workflow tools for finance, procurement and compliance teams that need monitoring, alerts and an API.
| Item | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|
| Revenue | 1 038 | 2 731 | 2 621 | 1 506 | 762 |
| Staff expenses | — | −808 | −972 | −957 | −888 |
| EBITDA | 420 | 1 826 | 1 379 | 262 | −351 |
| Depreciation & amort. | −0 | — | — | — | — |
| EBIT | 420 | 1 826 | 1 379 | 262 | −351 |
| Net financials | −1 228 | 639 | 53 | 40 | 34 |
| Profit before tax | 9 | 1 908 | 1 082 | 331 | 4 |
| Tax | −5 | −297 | −225 | −75 | −2 |
| Net profit | 4 | 1 612 | 857 | 256 | 2 |
| Item | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|
| Total assets | 2 355 | 4 783 | 5 763 | 5 464 | 4 926 |
| Equity | 1 838 | 3 449 | 3 907 | 4 163 | 4 165 |
| Long-term debt | 0 | — | — | — | — |
| Short-term debt | 378 | 764 | 936 | 411 | 191 |
| Total debt | 378 | 764 | 936 | 411 | 191 |
EBITDA margin
-46.0%
This company
15.8%
Market median
-391% vs market
20212025
Equity ratio
84.6%
This company
38.2%
Market median
+121% vs market
20212025
Return on equity
0.0%
This company
18.4%
Market median
-100% vs market
20212025
Net profit margin
0.3%
This company
8.1%
Market median
-96% vs market
20212025
Asset turnover
0.15×
This company
1.12×
Market median
-87% vs market
20212025
Debt / equity
0.18×
This company
0.62×
Market median
+71% vs market
20212025
- Annual report 2025Filed via Bolagsverket / SCB · Period 2025-01-01 – 2025-12-31
- Annual report 2024Filed via Bolagsverket / SCB · Period 2024-01-01 – 2024-12-31
- Annual report 2023Filed via Bolagsverket / SCB · Period 2023-01-01 – 2023-12-31
- Annual report 2022Filed via Bolagsverket / SCB · Period 2022-01-01 – 2022-12-31
- Annual report 2021Filed via Bolagsverket / SCB · Period 2021-01-01 – 2021-12-31
| Name | Role | Member since |
|---|---|---|
| Current (1) | ||
HO Chief Executive Officer | Chief Executive Officer | 2022 |
| Name | Role | Member since |
|---|---|---|
| Current (2) | ||
| Chairman | 2020 | |
| Deputy Board Member | 2022 | |
No shareholder data available.
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive. Learn more.
No registered parent or subsidiaries
Board members of Medicator Aktiebolag also hold positions in 0 other companies.
| Person | Role here | Other companies |
|---|---|---|
| Hans Olof Jesper Ek | Chief Executive Officer | 0 companies |
| Hans Ture Staffan Ek | Chairman | 0 companies |
| Margareta Christina Ek | Deputy Board Member | 0 companies |